Silvia Marsoni Silvia Marsoni LabItaly

Silvia Marsoni Candilo is a prominent figure in the field of cancer research and development. She has been active in cancer research for over 30 years, focusing on drug development and clinical trial methodology. Her work has been instrumental in designing and conducting pivotal large-scale trials, particularly in colon and lung cancer. Marsoni has also been involved in early drug development and the SENDO Foundation, which organized early phase trials for novel cytotoxic, targeted, and epigenetic drugs. Her research has led to significant achievements, including the establishment of trabectedin as a new drug for ovarian cancer. Marsoni's commitment to precision medicine and the development of predictive biomarkers in colon and lung cancers has been a driving force in her career.

Wednesday 10 June 2026

Time	Session

13:45 15:00	Career Development Session 2A (open to EACR Early Career & Student Members, pre-registration required) ElisaOricchio Coordinator ISREC-EPFLSwitzerland TABLE 2: Efficient and caring mentorship: how to make your research team flourish? Arkaitz Carracedo Perez Moderator CIC bioGUNESpain TABLE 3: Navigating a career in Academia and Industry AnnaBabayan Moderator IlluminaGermany TABLE 4: Building Equitable Research Careers for Women CarolineDive Moderator CRUK Cancer Biomarker CentreUnited Kingdom TABLE 5: Tips and tricks to publish your work SteveMao Moderator Cancer CellUnited States TABLE 6: How do you know when you are ready to start your own lab? MartaKovatcheva Moderator IFOMItaly TABLE 7: Establishing interdisciplinary collaborations in early independent careers Maria M.Caffarel Moderator Biogipuzkoa Health Research InstituteSpain TABLE 8: Navigating the transition from academia to publishing Siddhi Maniyar Moderator Molecular Oncology, FEBS PressGermany TABLE 9: Scientists and patient advocacy Marisol S.Soengas Moderator Spanish National Cancer Research Center (CNIO)Spain TABLE 10: How to start your lab and make it successful SandraBlanco Benavente Moderator Universidad de SalamancaSpain TABLE 11: What is needed to break the glass ceiling for women in science? AnaCuenda Moderator National Centre of Biotecnology (CNB-CSIC)Spain TABLE 12: Challenges of being a clinician scientist: Successfully balancing clinical and academic duties DanielKirschenbaum Moderator Deutsches Krebsforschungszentrum (DKFZ)Germany TABLE 13: Career transition to industry To beannounced Moderator NWM TESTING TABLE 14: Funding opportunities NicolaHawkes Moderator Worldwide Cancer ResearchUnited States TABLE 15: Funding opportunities AmaiaLujambio Moderator The Mark Foundation for Cancer ResearchUnited States TABLE 1: How to make your research impactful and transferable to the clinic Silvia Marsoni Moderator Silvia Marsoni LabItaly Career Development Area
15:20 16:55	Symposium: Advances in Clinical Trial Design: From biology to treatment Room P1+2+3 AlbertoBardelli Chair University of Torino / IFOM ETSItaly Integrative analyses of biomarker studies to transform advanced prostate cancer care Johannde Bono Speaker The Institute of Cancer Research, Drug Development UnitUnited Kingdom Proffered Paper: Urine Detection of MMP-7 As a Senescence Biomarker of Lung Cancer Therapy-Resistance Using an Injectable Nanoprobe EACR26-1820 EACR26-1820 MUNOZ-ESPINDANIEL Oral Presenter University of CambridgeUnited Kingdom Can we modify a cancer diagnosis to improve treatment? AlbertoBardelli Speaker University of Torino / IFOM ETSItaly Reading the Molecular Future of Colon Cancer in the Blood Silvia Marsoni Speaker Silvia Marsoni LabItaly Questions & Answers Room P1+2+3